Swedish Supreme Court Overrules National Food Agency’s Vitamin D Ban
December 8, 2018
Our Cellular Medicine Guide To Surviving The Year-End Party Season
December 10, 2018

New Study Finds Statin Drugs Are ‘Overprescribed’


A new study published in the British Medical Journal confirms that cholesterol-lowering statin drugs are overprescribed for primary prevention of cardiovascular disease.


The publication of this latest research comes only a matter of months after another study linked use of statins to the development of a potentially fatal muscle disease. Published in the journal JAMA Internal Medicine, patients with the muscle condition were found to be almost twice as likely to have been taking statins compared to similar individuals from the general population.

In addition to their adverse effects on muscles, a review of the scientific literature shows that statins can also raise the risk of cognitive problems; cancer; strokes; damage to the peripheral nervous system; sexual dysfunction; thyroid problems; kidney disease; behavioral disorders; heart problems; neurodegenerative disease; autoimmune diseases; pancreatic problems; liver disease; skin problems; gastrointestinal problems; fatigue; psychiatric problems; sleep problems; as well as negatively affecting many other aspects of health.

It is bad enough that millions of patients taking cholesterol-lowering drugs remain mostly unaware of these dangers. Arguably worse still however is the fact that the drugs also fail to address the primary cause of cardiovascular disease.

To learn about a groundbreaking study in which scientists at the Dr. Rath Research Institute proved that cardiovascular disease is essentially an early form of the vitamin C deficiency disease scurvy, read this press release on our website.

To find out how heart attacks, strokes, high blood pressure, and other cardiovascular conditions can be prevented and controlled naturally, without drugs, read Dr. Rath’s lifesaving book, Why Animals Don’t Get Heart Attacks…But People Do!

Read article in the Daily Mail (UK)